A recent OIG report found that diagnoses reported in 2022 Medicare Advantage (MA) encounter data based only on health risk ...

In a move that has woken the biomedical research community, the National Institutes of Health (NIH) announced on Friday, ...

A recent OIG report found that diagnoses reported in 2022 Medicare Advantage (MA) encounter data based only on health risk… ...

In the medical field, terminology not only guides clinical understanding and patient communication but also impacts research, ...

In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...

The year is 2030, you have been in the doctor's office for two hours, answering what seems like hundreds of questions on ...

The United States Centers for Medicare and Medicaid Services (CMS) recently announced that it will discontinue the Medicare ...

Legal, Regulatory, and Compliance Issues ...

Pfizer’s subsidiary Biohaven has agreed to a settlement nearing $60 million to resolve allegations of false claims related to ...

In one of the largest healthcare fraud cases in U.S. history, an Arizona couple has admitted to orchestrating a scheme that ...

The Drug Enforcement Administration and the HHS are extending flexibilities for providers prescribing controlled substances ...

Sandoz recently announced a $275 million settlement with its subsidiary Fougera Pharmaceuticals, to resolve allegations of ...